Introduction of SARS‐COV‐2 C.37 (WHO VOI lambda) from Peru to Italy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Introduction of SARS‐COV‐2 C.37 (WHO VOI lambda) from Peru to Italy

Published:2021-08-02 Issue:12 Volume:93 Page:6460-6461
ISSN:0146-6615
Container-title:Journal of Medical Virology
language:en
Short-container-title:J Med Virol

Author:

Baj Andreina¹²^ORCID,Novazzi Federica¹,Ferrante Francesca D.¹,Genoni Angelo²,Cassani Gianluca¹,Prestia Martina¹,Colombo Alberto¹,Capuano Riccardo¹,Zago Christian¹,Pasciuta Renee¹,Tamborini Antonio¹,Rossi Agostino¹,Tettamanzi Elena³,Catanoso Giuseppe³,Focosi Daniele²⁴,Maffioli Lorenzo⁵,Maggi Fabrizio¹²

Affiliation:

1. Laboratory of Microbiology, ASST Sette Laghi Varese Italy

2. Department of Medicine and Surgery University of Insubria Varese Italy

3. ATS Insubria Varese

4. North‐Western Tuscany Blood Bank Pisa University Hospital Pisa Italy

5. Chief Medical Officer ASST Sette Laghi Varese Italy

Publisher

Wiley

Subject

Infectious Diseases,Virology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jmv.27235

Reference7 articles.

1. Neutralising antibody escape of SARS‐CoV‐2 spike protein: Risk assessment for antibody‐based Covid‐19 therapeutics and vaccines

2. Tracking SARS‐CoV‐2 variants.https://www.who.int/en/activities/tracking-SARS-CoV-2-variants/

3. Structure-guided multivalent nanobodies block SARS-CoV-2 infection and suppress mutational escape

4. Complete map of SARS-CoV-2 RBD mutations that escape the monoclonal antibody LY-CoV555 and its cocktail with LY-CoV016

5. TadaT ZhouH DcostaBM SamanovicMI MulliganMJ LandauNR. SARS‐CoV‐2 lambda variant remains susceptible to neutralization by mRNA vaccine‐elicited antibodies and convalescent serum.bioRxiv. Published online July 03 2021.https://doi.org/10.1101/2021.07.02.450959

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Parallel Algorithm for Designing Primer and Probe for Accurate Detection of Severe Acute Respiratory Syndrome Coronavirus;Black Sea Journal of Engineering and Science;2023-10-15

2. Effectiveness of the BBIBP-CorV vaccine in preventing infection and death in health care workers in Peru 2021;Travel Medicine and Infectious Disease;2023-05

3. Evolution of SARS-CoV-2 Variants: Implications on Immune Escape, Vaccination, Therapeutic and Diagnostic Strategies;Viruses;2023-04-10

4. Evidence of natural selection and dominance of SARS-CoV-2 variant Lambda (C.37) over variants of concern in Cusco, Peru;Archives of Virology;2023-02-14

5. Host genetic diversity and genetic variations of SARS-CoV-2 in COVID-19 pathogenesis and the effectiveness of vaccination;International Immunopharmacology;2022-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3